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ABSTRACT
Objective: To analyse the composition of the serous fluid formed after axillary dissection
Design: Descriptive study
Setting: University hospital and teaching hospital, The Netherlands
Subjects: 16 patients whose axillas were dissected as part of a modified radical mastectomy for stage I or II breast cancer
Main outcome measures: Chemical and cellular composition of axillary drainage fluid on the first, fifth, and tenth postoperative
days compared with the same constituents in blood and with reported data on the composition of peripheral lymph.
Results and conclusion: On the first postoperative day the drainage fluid contained blood contents and a high concentration of
creatine phosphokinase (CPK). After day one it changed to a peripheral lymph-like fluid but containing different cells, more
protein, and no fibrinogen, making coagulation impossible. The reduction in the fluid production must be caused by other
wound healing processes, such as formation of scars and connective tissue.
Key words: axillary dissection, breast cancer, composition of drainage fluid.
INTRODUCTION
Non-haemorrhagic fluid commonly forms in wounds
after the dissection of axillary nodes and the collection
is known as a seroma. The origin of this fluid is not well
understood and studies on its origin and composition
are scarce (28). The name suggests that the fluid
originates from ultrafiltration of blood. Other explana-
tions for its formation are leakage of lymph from
disrupted lymphatics in the axilla (24, 27) and the
production of a wound exudate as part of the
inflammatory phase of wound healing (28).
We studied the composition of the fluid formed in
the axilla after dissection of axillary lymph nodes and
compared the results with the composition of blood of
the same patients and with reported data on the
composition of peripheral lymph. To distinguish it
from chyle, which can be sampled from the thoracic
duct, we use the term peripheral lymph, which is lymph
produced in the extremities and has not yet passed
through a node or come into contact with other
lymphoid structures (29). The aim of the study was to
analyse the chemical and cellular composition of
serous fluid from the axilla to shed some light on the
processes involved in its formation.
PATIENTS AND METHODS
Sixteen patients with breast cancer underwent axillary
dissection as part of a modified radical mastectomy as
prescribed by Madden (19). Criteria for exclusion were
the use of corticosteroids or anticoagulants, preopera-
tive radiotherapy or chemotherapy, and postoperative
hematoma or infection. Level I, II and III nodes were
resected. Low-dose heparin was used for prophylaxis
of deep venous thrombosis. The axilla was drained with
a closed suction drainage system. A separate drain was
used for the skin flaps of the mastectomy wound.
Drains were removed if less than 30 ml of fluid was
produced on two consecutive days. Samples of the
axillary drainage fluid were obtained on the first, fifth,
and tenth postoperative days. On the first postoperative
day a blood sample was also taken. The fluids were
assayed in the clinical laboratory of the Zuider
Hospital. Concentrations of the following substances
were measured: electrolytes—sodium, potassium, cal-
cium, magnesium, phosphate and iron; proteins—total
protein and albumin; electrophoresis- -1 globulins,  -2
globulins, ß globulins and gamma globulins; haemo-
globin, transferrin, IgG, and fibrinogen; lipids—trigly-
cerides and cholesterol; cells—platelets, red cells and
leucocytes; and glucose, osmolality and creatine
phosphokinase (CPK).
The mean values of the variables in blood and
drainage fluid were compared by independent group
analysis using a Tukey non-parametric multiple com-
parison test. Statistical analyses were done on a
personal computer using the Kwikstat version 4.1
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statistical data analysis package (TexaSoft, Cedar Hill,
Texas, USA).
RESULTS
Results of the analyses are shown in Table 1. No
patients had intermittent fluid formation, and no
patients had to be excluded because they produced
too little or no fluid.
The values of electrolytes in serous fluid were lower
for calcium compared with blood. The calcium:albu-
min ratio was 0.080 for serous fluid and 0.067 for
blood. The iron content was high on day 1 in serous
fluid which was also iso-osmotic (290 mOsm). Con-
centrations of CPK in serous fluid were extremely high
Table 1. Mean (SEM) concentrations of constituents of serous fluid after axillary dissection
Serous fluid
Variable
Blood
(n = 16)
Day 1
(n = 16)
Day 5
(n = 14)
Day 10
(n = 5) Comment*
Electrolytes
Sodium (mmol/L) 141.3 (0.7) 140.1 (0.6) 141.3 (0.5) 140.2 (1.4) No differences.
Potassium (mmol/L) 3.9 (0.1) 4.3 (0.1) 4.2 (0.1) 4.3 (0.1) No differences.
Calcium (mmol/L) 2.26 (0.03) 1.87 (0.04) 1.90 (0.03) 1.94 (0.04) Serous fluid lower than blood.
Magnesium (mmol/L) 0.75 (0.02) 0.80 (0.03) 0.74 (0.01) 0.78 (0.02) No differences.
Phosphate (mmol/L) 0.95 (0.05) 1.23 (0.12) 1.13 (0.06) 1.15 (0.08) No differences.
Iron ( mol/L) 10.9 (1.0) 25.4 (2.9) 13.1 (1.2) 14.4 (2.7) Serous fluid day 1 higher
than other values.
Proteins
Total protein (g/L) 57.7 (1.3) 42.8 (2.5) 37.0 (1.2) 39.2 (1.6) Serous fluid lower than blood.
Albumin (g/L) 33.8 (1.0) 23.2 (1.1) 24.6 (1.0) 26.0 (1.7) Serous fluid lower than blood.
Alpha-1 globulins (g/L) 3.17 (0.18) 1.51 (0.15) 1.53 (0.15) 1.48 (0.10) Serous fluid lower than blood.
Alpha-2 globulins (g/L) 5.8 (0.2) 2.6 (0.3) 2.4 (0.2) 2.3 (0.3) Serous fluid lower than blood.
Beta globulins (g/L) 7.3 (0.3) 8.3 (1.5) 3.5 (0.3) 4.5 (0.4) No difference serous fluid
day 1 and blood.
Gamma globulins (g/L) 8.1 (0.5) 5.2 (0.3) 4.1 (0.3) 5.0 (0.5) Serous fluid lower than blood.
Immunoglobulins G (g/L) 8.5 (0.6) 4.9 (0.3) 4.6 (0.3) 5.2 (0.6) Serous fluid lower than blood.
Haemoglobin (mmol/L) 7.79 (0.24) 1.74 (0.40) 0.25 (0.09) Trace Serous fluid lower than
blood. Rapid decline.
Transferrin ( mol/L) 54.1 (2.9) 32.5 (2.0) 32.0 (2.0) 31.4 (1.7) Serous fluid lower than blood.
Fibrinogen (g/L) 3.07 (0.21) 0.15 (0.02) 0.13 (0.02) Trace Serous fluid lower than blood.
Lipids
Triglycerides (mmol/L) 1.92 (0.50) 1.42 (0.21) 0.60 (0.06) 0.46 (0.05) No difference serous fluid
day 1 and blood.
Cholesterol (mmol/L) 4.6 (0.4) 2.4 (0.2) 1.8 (0.1) 2.1 (0.3) Serous fluid lower than blood.
Cells
Platelets ( 109/L) 248 (15) 64 (10) 21 (5) 16 (4) Serous fluid lower than
blood. Rapid decline.
Red cells ( 1012/L) 4.1 (0.1) 1.1 (0.2) 0.1 (0.04) Trace Serous fluid lower than
blood. Rapid decline.
Leucocytes ( 109/L) 10.1 (1.0) 10.6 (1.5) 1.3 (0.3) 0.3 (0.2) No difference serous fluid
day 1 and blood.
Differentiation
Neutrophils (%) 72.2 (3.2) 93 (1.8) Not measurable Not measurable
Lymphocytes (%) 22.2 (2.9) 6 (1.6) Not measurable Not measurable
Monocytes (%) 5.6 (1.2) 1 (0.6) Not measurable Not measurable
Eosinophils and
basophils (%)
0.8 (0.05) 0.1 (0.02) Not measurable Not measurable
Other
Glucose (mmol/L) 4.0 (0.05) 4.2 (0.3) 3.9 (0.1) 4.2 (0.2) No differences.
Osmolality (mOsm/L) 296 (3) 290 (2) 292 (2) 302 (10) No differences.
CPK (E/L) 223 (62) 22600 (3800) 2750 (1800) 75 (13) Extreme increase after operation
then rapid decline
* All differences statistical significant with p < 0.001. Tukey multiple comparison test.
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on day 1. Concentrations of all proteins were sig-
nificantly lower in serous fluid compared with blood
with the exception of   globulin, which did not differ
on day 1. Only very small amounts of fibrinogen were
found in the serous fluid. Red cells, platelets and
leucocytes were present in the fluid on day 1, but had
nearly gone on days 5 and 10. The serous fluid:blood
ratio on day 1 was similar for red cells and platelets
(0.26), but was much higher for leucocytes (1.05).
Differentiation of the leucocytes on day 1 showed 93%
neutrophils, 6% lymphocytes, and 1% monocytes.
DISCUSSION
Obviously during the first days the drainage fluid is
contaminated with blood from the surgical wound, so
iron, triglycerides, haemoglobin, and blood cells are
present in the fluid on day 1. They disappear rapidly
thereafter. The same goes for CPK, the presence of
which may be attributed to tissue destruction as a direct
result of the operation. In addition, the fluid is iso-
osmotic. The presence of fibrinogen from blood may
lead to the formation of some clots early in the wound
healing process, but later on, when the fibrinogen
originating from blood has been used up, this ceases.
Once constituents of blood have disappeared con-
centrations of electrolytes and glucose in the serous
fluid are similar to those in serum, with the exception of
calcium. For sodium, potassium, magnesium, phos-
phate, and calcium the reported concentrations in
lymph (5, 17, 21, 23, 29) are similar to those we found
in serous fluid. Iron is present in large quantities on the
first day, probably as a result of decomposition of
haemoglobin.
Concentrations of protein in the serous fluid are
lower than in plasma, but somewhat higher than in
peripheral lymph (10, 14, 18, 21, 25, 26). There is no
relation with the molecular weight of the proteins, and
there is no development over time.
What is striking about the fluid formed in the axilla is
the almost complete absence of fibrinogen. As a
consequence of this, it does not clot spontaneously so
clotting cannot be the cause of the reduced production
of fluid over time. This must, therefore, be caused by
other processes such as the formation of collagen and
connective tissue. This accords with the low concen-
tration of coagulation factors that is found in peripheral
lymph in animal studies (7, 16). In humans fibrinogen
can be measured only in thoracic duct lymph, in which
concentrations vary (9).
It has been suggested that the sealing of ruptured
lymphatics by the coagulation of lymph is an important
factor in the eventual cessation of leakage of lymph
after pelvic lymphadenectomy. This process may be
slowed down by the use of low-dose heparin. (8). The
absence of fibrinogen in fluid from the axilla makes
such a mechanism for the cessation of the production of
fluid unlikely. The mechanism by which tranexamic
acid acts in reducing the volume of axillary fluid
production, as reported recently (20), therefore remains
obscure (4).
The fluid in the axilla is cell-deficient. It contains
mainly leucocytes on day one, but the concentration of
cells rapidly declines with time. Granulocytes were the
dominant leucocytes, but we saw no shift to lympho-
cytes such as was reported in a previous study to be
associated with the exudative phase of wound healing
(28). Peripheral lymph contains appreciable counts of
lymphocytes (12, 13, 23, 26, 29), no platelets (15) and,
like serous fluid, only few red cells (12, 23, 29).
Some aspects on the composition of serous fluid
need further investigation, such as its role in wound
healing and the problem of protracted seroma forma-
tion after removal of the drain. The presence of a
seroma is considered to be a risk factor for wound
infection. Wound fluid collected from patients after
modified radical mastectomy impaired the neutrophil-
dependent killing of bacteria because of a deficiency in
the normal humoral factors such as complement and
fibronectin (6). The loss of opsonic activity of plasma
proteins in wound fluids progresses over time (3). We
found low concentrations of albumin and transferrin in
the drainage fluid, which may contribute to the inability
of the fluid to support lymphocyte blastogenesis to the
same extent as serum, a process necessary for wound
healing. This topic needs further elucidation in future
studies.
The development of seroma fluid around a prosthetic
graft in reconstructive vascular surgery is associated
with the presence of a fibroblast inhibitor in serum (1),
recently identified as a protein with a molecular weight
of 2000 Da. (2). Fibroblast inhibitors with low mole-
cular weights are also found in wound fluids and may
very well be part of a physiological regulatory
mechanism in wound healing (22). Macrophages
have a role in the production of these inhibitors (11).
It is still too early to speculate about the role of
inhibition of fibroblast growth as a factor in protracted
seroma production as happens in some patients after
surgery for breast cancer.
In conclusion, the serous fluid formed in the axilla
after lymph node dissection seems to be a peripheral
lymph-like fluid. However, the cell content is some-
what different from that of lymph, and it contains no
fibrinogen. Initially postoperatively the composition of
the fluid includes blood components, but these dis-
appear rapidly thereafter. The absence of fibrinogen,
precluding the coagulation of the fluid, has important
consequences for the process responsible for the
ultimate cessation of seroma production. The fluid
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shares little resemblance with a wound exudate,
because of the low concentration of cells, absence of
fibrinogen, and the low protein content.
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RE´ SUME´
But: Analyser la composition des lymphoce`les survenant
apre`s dissection du creux axillaire.
Type d’e´tude: Descriptive.
Provenance: Hoˆpital universitaire, Pays-Bas.
Patients: Seize patients ayant eu un curage axillaire associe´ a`
une mastectomie type Madden pour un cancer du sein stade I
ou II.
Principaux crite`res de jugement: La composition chimique
et la cellularite´ des liquides de drainage axillaire a` J1, J5, et
J10 postope´ratoires compare´s aux meˆmes parame`tres dans le
sang et aux donne´es receuillies sur la composition de la
lymphe pe´riphe´rique.
Re´sultats et conclusions: Le premier jour postope´ratoire
l’e´panchement contient du sang et une concentration e´leve´e
de cre´atine phosphokinase (CPK). Apre`s le premier jour il a
les caracte´ristiques d’un e´panchement lymphatique pe´riph-
e´rique mais contient diffe´rentes cellules, plus de prote´ines, et
pas de fibrinoge´ne, ce qui rend impossible sa coagulation. La
diminution de la production de l’e´panchement peut eˆtre
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obtenue par d’autres processus de cicatrisation, tels que la
formation de fibrose et de tissu conjonctif.
Mots-cle´s: Dissection du creux axillaire, cancer du sein,
composition des lymphoce`les.
ZUSAMMENFASSUNG
Ziel: Die Analyse der Zusammensetzung der sero¨sen
Flu¨ssigkeit nach Dissektion der Achselho¨hle.
Studienanordnung: Deskriptive Studie.
Studienort: Universita¨tsklinik und Lehrkrankenhaus. Nie-
derlande.
Patienten: 16 Patienten deren Achselho¨hlen disseziert
worden waren als Teil einer modifizierten radikalen Mas-
tektomie bei Brustkarzinom Stadium I oder II.
Endpunkte: Chemische und zellula¨re Komposition der
Drainagenflu¨ssigkeit am ersten, fu¨nften und zehnten post-
operativen Tag im Vergleich mit den gleichen Komponenten
im Blut und Referenzwerten zur Komposition der Lymphe.
Ergebnisse und Schlussfolgerung: Am ersten postoperativen
Tag besteht die Seromflu¨ssigkeit aus Blut und hat eine hohe
Konzentration von Kreatinphosphokinase (CPK). Nach dem
ersten Tag vera¨ndert sich die Flu¨ssigkeit in eine die periphere
Lymphe-a¨hnliche Flu¨ssigkeit, die verschiedene Zellarten
und mehr Protein entha¨llt. Sie entha¨llt aber kein Fibrinogen,
wodurch die Koagulation unmo¨glich wird. Die Abnahme der
Produktion von Seromflu¨ssigkeit muss daher durch andere
Wundheilungsprozesse verursacht werden, wie die Bildung
von Narben und Bindegewebe.
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